1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Giant Cell Arteritis Global Clinical Trials Review, H2, 2014

Giant Cell Arteritis Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 70 pages

Giant Cell Arteritis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Giant Cell Arteritis Global Clinical Trials Review, H2, 2014" provides data on the Giant Cell Arteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Giant Cell Arteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Giant Cell Arteritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Giant Cell Arteritis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Giant Cell Arteritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Giant Cell Arteritis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Giant Cell Arteritis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 28
Laboratorios Servier, S.L. 29
Clinical Trial Overview of Laboratorios Servier, S.L. 29
Janssen Global Services, LLC 30
Clinical Trial Overview of Janssen Global Services, LLC 30
Clinical Trial Overview of Top Institutes / Government 31
University of Oxford 31
Clinical Trial Overview of University of Oxford 31
Centre Hospitalier Universitaire Dijon 32
Clinical Trial Overview of Centre Hospitalier Universitaire Dijon 32
Japan Intractable Diseases Research Foundation 33
Clinical Trial Overview of Japan Intractable Diseases Research Foundation 33
FDA Office of Orphan Products Development 34
Clinical Trial Overview of FDA Office of Orphan Products Development 34
Saitama Medical University 35
Clinical Trial Overview of Saitama Medical University 35
University of Bern 36
Clinical Trial Overview of University of Bern 36
Caen University Hospital 37
Clinical Trial Overview of Caen University Hospital 37
University Hospital, Toulouse 38
Clinical Trial Overview of University Hospital, Toulouse 38
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Five Key Clinical Profiles 41
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70

List of Tables
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Giant Cell Arteritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Giant Cell Arteritis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 28
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Servier, S.L., 2014* 29
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 30
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 31
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire Dijon, 2014* 32
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Intractable Diseases Research Foundation, 2014* 33
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014* 34
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 35
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 36
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Caen University Hospital, 2014* 37
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014* 38
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 39
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 40

List of Figures
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.